Dear Editor,
We would like to share ideas on “Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection.”1 Singh et al concluded that early use of anti-interleukin 6 therapy may be associated with improved hospital mortality and reduction in progression to more severe COVID-19. Tocilizumab is a possible useful drug for management of COVID-19. Since this was a …
Correspondence: Rujittika Mungmunpuntipantip, private academic consultant, Bangkok, Thailand. E-mail: rujittika{at}gmail.com
